scholarly journals P7‐63: Real world comparative effectiveness and tolerability of glycopyrronium/formoterol (G/F – 25 μG/12 μG) versus glycopyrronium/formoterol (G/F – 25 μG/6 μG) dry powder inhaler in COPD patients – Retrospective study

Respirology ◽  
2021 ◽  
Vol 26 (S3) ◽  
pp. 284-284
Keyword(s):  
Retrospective Study ◽  
Real World ◽  
Comparative Effectiveness ◽  
Dry Powder Inhaler ◽  
Dry Powder ◽  
Copd Patients

Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy

2021 ◽  
Author(s):  
Janwillem Kocks ◽  
Hans Wouters ◽  
Sinthia Bosnic-Anticevich ◽  
Joyce Van Cooten ◽  
Jaime Correia De Sousa ◽  
...  
Keyword(s):  
Health Status ◽  
Maintenance Therapy ◽  
Dry Powder Inhaler ◽  
Dry Powder ◽  
Factors Associated ◽  
Copd Patients

Late Breaking Abstract - Ability of Hong Kong COPD patients to inhale dry powder inhaler

2019 ◽  
Author(s):  
Chun Lung Lee ◽  
Veronica Lee Chan ◽  
Polly Ka Po Pang ◽  
Suet Lai Cheng ◽  
Sui Na Tsui ◽  
...  
Keyword(s):  
Hong Kong ◽  
Dry Powder Inhaler ◽  
Dry Powder ◽  
Copd Patients

scholarly journals Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions

2015 ◽  
Vol 28 (5) ◽  
pp. 309-319 ◽  
Author(s):  
Giorgio Walter Canonica ◽  
Jan Arp ◽  
Johan René Keegstra ◽  
Henry Chrystyn
Keyword(s):  
Real World ◽  
Dry Powder Inhaler ◽  
Dry Powder ◽  
Dose Consistency
Sign in / Sign up

Export Citation Format

Share Document